CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE; TRETINOIN
✉ Email this page to a colleague
All Clinical Trials for clindamycin phosphate; tretinoin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00823901 ↗ | Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea | Completed | Medicis Pharmaceutical Corporation | Phase 2/Phase 3 | 2009-02-01 | The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea. |
NCT00823901 ↗ | Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea | Completed | Massachusetts General Hospital | Phase 2/Phase 3 | 2009-02-01 | The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea. |
NCT00838812 ↗ | Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate | Completed | Igefarma Laboratorios S.A. | Phase 3 | 2009-03-01 | The purpose of this study is to determine the safety and efficacy of association between tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for clindamycin phosphate; tretinoin
Condition Name
Clinical Trial Locations for clindamycin phosphate; tretinoin
Trials by Country
Clinical Trial Progress for clindamycin phosphate; tretinoin
Clinical Trial Phase
Clinical Trial Sponsors for clindamycin phosphate; tretinoin
Sponsor Name